Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind Comparison of LY2140023, Olanzapine, and Placebo in the Treatment of Patients With Schizophrenia

NCT00149292 is registered in ClinicalTrials.gov with Denovo Biopharma LLC as lead sponsor.

NCT NCT00149292
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00149292 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind Comparison of LY2140023, Olanzapine, and Placebo in the Treatment of Patients With Schizophrenia
Lead sponsor
Denovo Biopharma LLC
Phase
Phase 2
Overall status
Completed
Start date
August 23, 2005
Completion date
July 17, 2006
Enrollment
195 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia